Renuka Malik, MDAssistant Professor of Radiation and Cellular OncologyRenuka Malik, MD, specializes in the treatment of thoracic, gastrointestinal, and oligometastatic cancers. She has expertise in stereotactic ablative radiotherapy, which employs larger than conventional doses of radiation to treat localized volumes with more potent forms of radiation. She is an expert in advanced technologies such as image-guided radiation therapy and intensity-modulated radiation therapy (IMRT), which minimizes damage to healthy tissues when targeting tumors. In addition to her clinical responsibilities, Dr. Malik serves as quality assurance chair for the Department of Radiation and Cellular Oncology. In this role, she works to ensure that patients receive highly effective and safe care. Dr. Malik is the lead investigator on a long-term study designed to assess outcomes for lung cancer patients treated with definitive radiotherapy. An accomplished author, she has published numerous articles in peer-reviewed journals and presented her research at several national and international meetings.
Practice LocationThe University of Chicago Medicine
Year Started Practice2011 Board CertificationRadiation Oncology Medical SchoolUniversity of Chicago Pritzker School of Medicine InternshipResurrection Medical Center, Chicago ResidencyThe University of Chicago Medicine
MembershipsAmerican Society of Therapeutic Radiology and Oncology Language SpokenEnglish Office Phone(773) 702-6870 Office Fax(773) 834-7340 Office Postal AddressRenuka Malik, MD
|
Clinical Interests
Request an appointment online
Read More About Dr. MalikAs part of a group of researchers from the University of Chicago, Dr. Malik found that molecular markers could predict the spread of cancer and, in turn, guide treatment.
Selected PublicationsView a partial list of Dr. Malik's publications through the National Library of Medicine's PubMed online database. |
